Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine for Toxicity in RADPLAT for Head and Neck Cancer
NCT00003580Phase 2Completed
- Sponsor
- University of Tennessee
- Start
- Jun 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in mucositis, acute radiation syndrome (ARS), Drug toxicity, sponsored by University of Tennessee. Started Jun 1998; status: completed.
02
Drugs
amifostine
03
Conditions
mucositisacute radiation syndrome (ARS)Drug toxicity
Beyond the preview
Go deeper on NCT00003580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003580.